Skip to content

Clinical trials

Completed Phase 3 Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20052
20062
20082
20104
20111
20121
20131
20144
20153
20173
20184
20203
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
Amgen3
BioMarin Pharmaceutical3
Ellodi Pharmaceuticals, LP3
AOP Orphan Pharmaceuticals AG2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Pfizer2
Seagen Inc.2
The First Affiliated Hospital of Soochow University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases46
Bone Marrow Diseases8
Anemia, Sickle Cell7
Genetic Diseases, Inborn7
Hemorrhagic Disorders7
Blood Coagulation Disorders6
Hemophilia A6
Hemostatic Disorders6
Blood Coagulation Disorders, Inherited5
Coagulation Protein Disorders5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.